A similar series of analyses were performed for the individuals with gastric cancer, and the same conclusion was reached, i.e., higher TMUB1 levels were associated with higher PD-L1 levels and worse clinical outcomes in the patients with gastric carcinoma (Fig. 5i–p and Supplementary Fig. 9c, d). The gene discussed is TMUB1; the disease is gastric cancer.